IGM Biosciences Inc (IGMS)
9.18
-0.11
(-1.18%)
USD |
NASDAQ |
May 17, 16:00
9.18
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Cash from Operations (Quarterly): -42.42M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -42.42M |
| December 31, 2023 | -48.01M |
| September 30, 2023 | -40.12M |
| June 30, 2023 | -53.10M |
| March 31, 2023 | -51.00M |
| December 31, 2022 | -37.86M |
| September 30, 2022 | -40.41M |
| June 30, 2022 | 111.31M |
| March 31, 2022 | -38.89M |
| December 31, 2021 | -35.30M |
| September 30, 2021 | -34.41M |
| Date | Value |
|---|---|
| June 30, 2021 | -27.01M |
| March 31, 2021 | -28.26M |
| December 31, 2020 | -23.34M |
| September 30, 2020 | -15.08M |
| June 30, 2020 | -13.08M |
| March 31, 2020 | -16.39M |
| December 31, 2019 | -12.07M |
| September 30, 2019 | -15.38M |
| June 30, 2019 | -9.324M |
| March 31, 2019 | -8.345M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-53.10M
Minimum
Jun 2023
111.31M
Maximum
Jun 2022
-23.51M
Average
-31.33M
Median
Cash from Operations (Quarterly) Benchmarks
| Akoya Biosciences Inc | -20.82M |
| Xilio Therapeutics Inc | -10.50M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 8.651M |
| Cash from Financing (Quarterly) | 0.152M |
| Free Cash Flow | -194.58M |
| Free Cash Flow Per Share (Quarterly) | -0.7469 |
| Free Cash Flow to Equity (Quarterly) | -44.90M |
| Free Cash Flow to Firm (Quarterly) | -44.90M |
| Free Cash Flow Yield | -37.56% |